Q3 2025 Earnings Call Transcript November 6, 2025 Novavax, Inc. misses on earnings expectations. Reported EPS is $-1.24654 ...

Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the third quarter ended ...

Novavax Inc (NVAX) focuses on innovation and partnerships amid financial hurdles, aiming for profitability by 2028.

Pfizer Inc said on Monday its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major victory in the fight against the pandemic.

Chances are good that you've heard a lot of ways to avoid, treat or cure COVID-19 (coronavirus disease 2019). If what you heard doesn't mention a COVID-19 vaccine or COVID-19 medicine from your ...

NORTHAMPTON, MA / ACCESS Newswire / November 4, 2025 / Public policies are central factors in determining healthcare interventions and access to medicines and treatment. Viatris leverages our global ...

Seasoned leader, philanthropist, and mother to drive the nation's leading tutoring and test prep provider into its next era of growth and innovation ORADELL, NJ / ACCESS Newswire / October 30, 2025 / ...

Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...

Novavax raised its annual revenue forecast for the third time this year on Thursday, banking on milestone payments from ...

GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Novavax Inc. (NVAX) on Thursday reported a loss of $202.4 million in its third quarter. On a per-share basis, the Gaithersburg, Maryland-based company ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...